SARS-CoV-2 Envelope Protein (SARS-CoV-2 E) (AA 101-222)

Catalog No. ABIN7505812

This Recombinant SARS-CoV-2 Envelope protein is produced in Escherichia coli (E. coli).

Quick Overview for SARS-CoV-2 Envelope Protein (SARS-CoV-2 E) (AA 101-222) (ABIN7505812)

Target: SARS-CoV-2 Envelope (SARS-CoV-2 E)

Protein Type: Recombinant

Origin: SARS Coronavirus-2 (SARS-CoV-2)

Source: Escherichia coli (E. coli)

Purity: > 90 % as determined by reducing SDS-PAGE.

Product Details

Protein Characteristics: AA 101-222

Sequence: Arg101-Gln222

Characteristics: A DNA sequence encoding the 2019-nCoV M protein (P0DTC5) (101-222) was expressed with a polyhistidine tag at the N-terminus.

Application Details

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4., 5 % trehalose, 5 % mannitol, 0.01 % tween-80.
Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween80 are added as protectants before lyophilization.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Expiry Date: 12 months

Target Details

Target: SARS-CoV-2 Envelope (SARS-CoV-2 E)

Alternative Name: SARS-CoV-2 E

Background:

Abbreviation: Membrane

Target Synonym: Membrane protein,E1 glycoprotein,Matrix glycoprotein,Membrane glycoprotein

Background: Component of the viral envelope that plays a central role in virus morphogenesis and assembly via its interactions with other viral proteins.Regulates the localization of S protein at cis-Golgi, the place of virus budding.May act by binding cytoplasmic c-terminus of S.

Molecular Weight:

Calculated MW: 15.9 kDa

Observed MW: 17 kDa

UniProt: P0DTC5